Ir para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • The value of bone turnover mar...
  • Citar
  • Enviar por SMS
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Permanent link
The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.

Show other versions (1)
Detalhes bibliográficos
Main Authors: van Staa, T, Eastell, R, Barton, I, Rizzoli, R, Javaid, M, Cooper, C
Formato: Conference item
Publicado em: 2003
  • Exemplares
  • Descrição
  • Other Versions (1)
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
    Por: van Staal, T, et al.
    Publicado em: (2003)
  • PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS
    Por: van Staa, T, et al.
    Publicado em: (2003)
  • Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Por: Van Staa, T, et al.
    Publicado em: (2003)
  • Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
    Por: Watts, N, et al.
    Publicado em: (2004)
  • Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
    Por: Watts, N, et al.
    Publicado em: (2004)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs